nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CYP2C8—Pyrimethamine—malaria	0.0357	0.0538	CbGbCtD
Bortezomib—CYP2C8—Sulfadiazine—malaria	0.0357	0.0538	CbGbCtD
Bortezomib—CYP1A1—Quinine—malaria	0.0319	0.048	CbGbCtD
Bortezomib—CYP1A1—Quinidine—malaria	0.028	0.0422	CbGbCtD
Bortezomib—CYP2C19—Artemether—malaria	0.0255	0.0384	CbGbCtD
Bortezomib—CYP3A4—Clindamycin—malaria	0.0252	0.038	CbGbCtD
Bortezomib—CYP2C9—Pyrimethamine—malaria	0.0249	0.0375	CbGbCtD
Bortezomib—CYP2C9—Sulfadiazine—malaria	0.0249	0.0375	CbGbCtD
Bortezomib—PTGS1—Dapsone—malaria	0.0242	0.0364	CbGbCtD
Bortezomib—CYP2C19—Proguanil—malaria	0.024	0.0361	CbGbCtD
Bortezomib—CYP2D6—Pyrimethamine—malaria	0.0228	0.0343	CbGbCtD
Bortezomib—CYP1A2—Proguanil—malaria	0.0221	0.0333	CbGbCtD
Bortezomib—CYP2C9—Artemether—malaria	0.0212	0.0319	CbGbCtD
Bortezomib—CYP2C9—Proguanil—malaria	0.0199	0.03	CbGbCtD
Bortezomib—CYP2D6—Artemether—malaria	0.0194	0.0292	CbGbCtD
Bortezomib—CYP2C8—Quinine—malaria	0.0184	0.0277	CbGbCtD
Bortezomib—CYP2D6—Proguanil—malaria	0.0182	0.0274	CbGbCtD
Bortezomib—CYP2D6—Quinidine barbiturate—malaria	0.0173	0.026	CbGbCtD
Bortezomib—CYP2C8—Quinidine—malaria	0.0162	0.0243	CbGbCtD
Bortezomib—CYP1A2—Pentoxifylline—malaria	0.0159	0.0239	CbGbCtD
Bortezomib—CYP2C19—Quinine—malaria	0.0154	0.0232	CbGbCtD
Bortezomib—CYP3A4—Sulfadiazine—malaria	0.0145	0.0218	CbGbCtD
Bortezomib—CYP1A2—Quinine—malaria	0.0142	0.0214	CbGbCtD
Bortezomib—CYP2C8—Dapsone—malaria	0.0139	0.021	CbGbCtD
Bortezomib—CYP2C9—Quinine—malaria	0.0128	0.0193	CbGbCtD
Bortezomib—CYP1A2—Quinidine—malaria	0.0125	0.0188	CbGbCtD
Bortezomib—CYP3A4—Artemether—malaria	0.0123	0.0185	CbGbCtD
Bortezomib—CYP2D6—Quinine—malaria	0.0117	0.0177	CbGbCtD
Bortezomib—CYP2C19—Dapsone—malaria	0.0117	0.0176	CbGbCtD
Bortezomib—CYP3A4—Proguanil—malaria	0.0116	0.0174	CbGbCtD
Bortezomib—CYP2C9—Quinidine—malaria	0.0113	0.017	CbGbCtD
Bortezomib—CYP3A4—Doxycycline—malaria	0.011	0.0165	CbGbCtD
Bortezomib—CYP2D6—Quinidine—malaria	0.0103	0.0155	CbGbCtD
Bortezomib—CYP2C9—Dapsone—malaria	0.00973	0.0146	CbGbCtD
Bortezomib—CYP3A4—Quinine—malaria	0.00746	0.0112	CbGbCtD
Bortezomib—CYP3A4—Quinidine—malaria	0.00656	0.00988	CbGbCtD
Bortezomib—CTSG—blood plasma—malaria	0.00591	0.0546	CbGeAlD
Bortezomib—CYP3A4—Dapsone—malaria	0.00566	0.00852	CbGbCtD
Bortezomib—CTSG—hematopoietic system—malaria	0.00327	0.0302	CbGeAlD
Bortezomib—PSMA1—hematopoietic system—malaria	0.00314	0.029	CbGeAlD
Bortezomib—PSMD1—saliva-secreting gland—malaria	0.00276	0.0255	CbGeAlD
Bortezomib—PSMD2—saliva-secreting gland—malaria	0.00244	0.0226	CbGeAlD
Bortezomib—PSMB8—saliva-secreting gland—malaria	0.00243	0.0224	CbGeAlD
Bortezomib—PSMD2—hematopoietic system—malaria	0.00233	0.0215	CbGeAlD
Bortezomib—PSMA1—digestive system—malaria	0.00218	0.0201	CbGeAlD
Bortezomib—CTSG—blood—malaria	0.00216	0.02	CbGeAlD
Bortezomib—PSMB5—saliva-secreting gland—malaria	0.00215	0.0198	CbGeAlD
Bortezomib—CTSG—bone marrow—malaria	0.00209	0.0193	CbGeAlD
Bortezomib—PSMA1—bone marrow—malaria	0.00201	0.0186	CbGeAlD
Bortezomib—PSMD2—kidney—malaria	0.00191	0.0177	CbGeAlD
Bortezomib—PSMB1—saliva-secreting gland—malaria	0.00188	0.0173	CbGeAlD
Bortezomib—PSMB2—saliva-secreting gland—malaria	0.00183	0.0169	CbGeAlD
Bortezomib—PSMB1—hematopoietic system—malaria	0.00179	0.0165	CbGeAlD
Bortezomib—PSMB2—hematopoietic system—malaria	0.00175	0.0161	CbGeAlD
Bortezomib—PSMD1—blood—malaria	0.00174	0.0161	CbGeAlD
Bortezomib—PSMD1—bone marrow—malaria	0.00169	0.0156	CbGeAlD
Bortezomib—PSMA1—liver—malaria	0.00162	0.015	CbGeAlD
Bortezomib—PSMD2—digestive system—malaria	0.00162	0.015	CbGeAlD
Bortezomib—SLC31A1—saliva-secreting gland—malaria	0.00158	0.0146	CbGeAlD
Bortezomib—PSMD2—blood—malaria	0.00154	0.0143	CbGeAlD
Bortezomib—PSMB8—blood—malaria	0.00154	0.0142	CbGeAlD
Bortezomib—PSMD2—bone marrow—malaria	0.00149	0.0138	CbGeAlD
Bortezomib—PSMB8—bone marrow—malaria	0.00149	0.0137	CbGeAlD
Bortezomib—PSMB1—kidney—malaria	0.00147	0.0135	CbGeAlD
Bortezomib—PSMB2—kidney—malaria	0.00143	0.0132	CbGeAlD
Bortezomib—PSMD1—liver—malaria	0.00136	0.0126	CbGeAlD
Bortezomib—PSMB5—blood—malaria	0.00136	0.0125	CbGeAlD
Bortezomib—PSMB5—bone marrow—malaria	0.00131	0.0121	CbGeAlD
Bortezomib—PSMA1—brain—malaria	0.00129	0.0119	CbGeAlD
Bortezomib—PSMB1—digestive system—malaria	0.00124	0.0115	CbGeAlD
Bortezomib—SLC31A1—kidney—malaria	0.00124	0.0114	CbGeAlD
Bortezomib—PSMB2—digestive system—malaria	0.00121	0.0112	CbGeAlD
Bortezomib—PSMD2—liver—malaria	0.00121	0.0112	CbGeAlD
Bortezomib—PSMB8—liver—malaria	0.0012	0.0111	CbGeAlD
Bortezomib—PSMB1—blood—malaria	0.00119	0.011	CbGeAlD
Bortezomib—PSMB2—blood—malaria	0.00116	0.0107	CbGeAlD
Bortezomib—CYP2C19—blood plasma—malaria	0.00115	0.0106	CbGeAlD
Bortezomib—PSMB1—bone marrow—malaria	0.00115	0.0106	CbGeAlD
Bortezomib—PSMB2—bone marrow—malaria	0.00112	0.0103	CbGeAlD
Bortezomib—PSMD1—brain—malaria	0.00108	0.01	CbGeAlD
Bortezomib—PSMB5—liver—malaria	0.00106	0.0098	CbGeAlD
Bortezomib—SLC31A1—digestive system—malaria	0.00105	0.00971	CbGeAlD
Bortezomib—CYP2C8—blood plasma—malaria	0.00101	0.00929	CbGeAlD
Bortezomib—SLC31A1—blood—malaria	0.001	0.00925	CbGeAlD
Bortezomib—SLC31A1—bone marrow—malaria	0.000969	0.00895	CbGeAlD
Bortezomib—PSMD2—brain—malaria	0.000959	0.00885	CbGeAlD
Bortezomib—PSMB8—brain—malaria	0.000953	0.0088	CbGeAlD
Bortezomib—CYP1A2—blood plasma—malaria	0.000942	0.0087	CbGeAlD
Bortezomib—PSMB1—liver—malaria	0.000927	0.00856	CbGeAlD
Bortezomib—PTGS1—endothelium—malaria	0.000919	0.00849	CbGeAlD
Bortezomib—PSMB2—liver—malaria	0.000905	0.00836	CbGeAlD
Bortezomib—CYP2C9—blood plasma—malaria	0.000894	0.00825	CbGeAlD
Bortezomib—PSMB5—brain—malaria	0.000842	0.00777	CbGeAlD
Bortezomib—PTGS1—blood plasma—malaria	0.000816	0.00754	CbGeAlD
Bortezomib—SLC31A1—liver—malaria	0.000783	0.00724	CbGeAlD
Bortezomib—PSMB1—brain—malaria	0.000736	0.00679	CbGeAlD
Bortezomib—PSMB2—brain—malaria	0.000718	0.00663	CbGeAlD
Bortezomib—CYP3A4—blood plasma—malaria	0.000681	0.00629	CbGeAlD
Bortezomib—CYP2D6—blood plasma—malaria	0.000671	0.00619	CbGeAlD
Bortezomib—CYP2C19—hematopoietic system—malaria	0.000637	0.00589	CbGeAlD
Bortezomib—SLC31A1—brain—malaria	0.000622	0.00574	CbGeAlD
Bortezomib—CYP2C8—hematopoietic system—malaria	0.000556	0.00514	CbGeAlD
Bortezomib—CYP1A2—hematopoietic system—malaria	0.000521	0.00481	CbGeAlD
Bortezomib—CYP1A1—hematopoietic system—malaria	0.000514	0.00474	CbGeAlD
Bortezomib—CYP2C9—hematopoietic system—malaria	0.000494	0.00456	CbGeAlD
Bortezomib—CYP2C8—kidney—malaria	0.000456	0.00421	CbGeAlD
Bortezomib—PTGS1—hematopoietic system—malaria	0.000451	0.00417	CbGeAlD
Bortezomib—CYP2C19—digestive system—malaria	0.000443	0.00409	CbGeAlD
Bortezomib—CYP2C19—blood—malaria	0.000422	0.0039	CbGeAlD
Bortezomib—CYP1A1—kidney—malaria	0.000421	0.00389	CbGeAlD
Bortezomib—CYP3A4—hematopoietic system—malaria	0.000377	0.00348	CbGeAlD
Bortezomib—CYP2D6—hematopoietic system—malaria	0.000371	0.00343	CbGeAlD
Bortezomib—PTGS1—kidney—malaria	0.00037	0.00342	CbGeAlD
Bortezomib—CYP2C8—blood—malaria	0.000369	0.0034	CbGeAlD
Bortezomib—CYP1A2—digestive system—malaria	0.000362	0.00334	CbGeAlD
Bortezomib—CYP1A1—digestive system—malaria	0.000357	0.0033	CbGeAlD
Bortezomib—CYP1A2—blood—malaria	0.000345	0.00319	CbGeAlD
Bortezomib—CYP2C9—digestive system—malaria	0.000344	0.00317	CbGeAlD
Bortezomib—CYP1A1—blood—malaria	0.00034	0.00314	CbGeAlD
Bortezomib—CYP2C19—liver—malaria	0.00033	0.00305	CbGeAlD
Bortezomib—CYP2C9—blood—malaria	0.000327	0.00302	CbGeAlD
Bortezomib—PTGS1—digestive system—malaria	0.000314	0.0029	CbGeAlD
Bortezomib—CYP3A4—kidney—malaria	0.000309	0.00285	CbGeAlD
Bortezomib—CYP2D6—kidney—malaria	0.000304	0.00281	CbGeAlD
Bortezomib—PTGS1—blood—malaria	0.000299	0.00276	CbGeAlD
Bortezomib—CYP2C8—liver—malaria	0.000288	0.00266	CbGeAlD
Bortezomib—CYP1A2—liver—malaria	0.00027	0.00249	CbGeAlD
Bortezomib—CYP1A1—liver—malaria	0.000266	0.00246	CbGeAlD
Bortezomib—CYP3A4—digestive system—malaria	0.000262	0.00242	CbGeAlD
Bortezomib—CYP2D6—digestive system—malaria	0.000258	0.00238	CbGeAlD
Bortezomib—CYP2C9—liver—malaria	0.000256	0.00236	CbGeAlD
Bortezomib—CYP3A4—blood—malaria	0.00025	0.00231	CbGeAlD
Bortezomib—CYP2D6—blood—malaria	0.000246	0.00227	CbGeAlD
Bortezomib—CYP2C8—brain—malaria	0.000229	0.00211	CbGeAlD
Bortezomib—CYP1A1—brain—malaria	0.000211	0.00195	CbGeAlD
Bortezomib—CYP3A4—liver—malaria	0.000195	0.0018	CbGeAlD
Bortezomib—CYP2D6—liver—malaria	0.000192	0.00177	CbGeAlD
Bortezomib—Erythema multiforme—Quinidine barbiturate—malaria	0.000192	0.00111	CcSEcCtD
Bortezomib—Muscle spasms—Clindamycin—malaria	0.000192	0.00111	CcSEcCtD
Bortezomib—Decreased appetite—Sulfadiazine—malaria	0.00019	0.0011	CcSEcCtD
Bortezomib—Eye disorder—Quinidine barbiturate—malaria	0.00019	0.0011	CcSEcCtD
Bortezomib—Tinnitus—Quinidine barbiturate—malaria	0.000189	0.00109	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000189	0.00109	CcSEcCtD
Bortezomib—Cardiac disorder—Quinidine barbiturate—malaria	0.000189	0.00109	CcSEcCtD
Bortezomib—Flushing—Quinidine barbiturate—malaria	0.000189	0.00109	CcSEcCtD
Bortezomib—Flushing—Pentoxifylline—malaria	0.000188	0.00109	CcSEcCtD
Bortezomib—Vertigo—Dapsone—malaria	0.000186	0.00107	CcSEcCtD
Bortezomib—PTGS1—brain—malaria	0.000185	0.00171	CbGeAlD
Bortezomib—Vision blurred—Quinine—malaria	0.000185	0.00107	CcSEcCtD
Bortezomib—Vision blurred—Quinidine—malaria	0.000185	0.00107	CcSEcCtD
Bortezomib—Anaemia—Clindamycin—malaria	0.000185	0.00107	CcSEcCtD
Bortezomib—Tremor—Quinidine—malaria	0.000184	0.00106	CcSEcCtD
Bortezomib—Tremor—Quinine—malaria	0.000184	0.00106	CcSEcCtD
Bortezomib—Immune system disorder—Quinidine barbiturate—malaria	0.000184	0.00106	CcSEcCtD
Bortezomib—Immune system disorder—Pentoxifylline—malaria	0.000183	0.00106	CcSEcCtD
Bortezomib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000183	0.00106	CcSEcCtD
Bortezomib—Chills—Quinidine barbiturate—malaria	0.000182	0.00105	CcSEcCtD
Bortezomib—Arrhythmia—Pentoxifylline—malaria	0.000181	0.00105	CcSEcCtD
Bortezomib—Cough—Dapsone—malaria	0.00018	0.00104	CcSEcCtD
Bortezomib—Agitation—Quinine—malaria	0.00018	0.00104	CcSEcCtD
Bortezomib—Agitation—Quinidine—malaria	0.00018	0.00104	CcSEcCtD
Bortezomib—Vertigo—Clindamycin—malaria	0.000179	0.00104	CcSEcCtD
Bortezomib—Angioedema—Quinidine—malaria	0.000179	0.00103	CcSEcCtD
Bortezomib—Angioedema—Quinine—malaria	0.000179	0.00103	CcSEcCtD
Bortezomib—Gastrointestinal pain—Sulfadiazine—malaria	0.000179	0.00103	CcSEcCtD
Bortezomib—Leukopenia—Clindamycin—malaria	0.000179	0.00103	CcSEcCtD
Bortezomib—Mental disorder—Quinidine barbiturate—malaria	0.000178	0.00103	CcSEcCtD
Bortezomib—Erythema—Quinidine barbiturate—malaria	0.000177	0.00102	CcSEcCtD
Bortezomib—Malnutrition—Quinidine barbiturate—malaria	0.000177	0.00102	CcSEcCtD
Bortezomib—Erythema—Pentoxifylline—malaria	0.000177	0.00102	CcSEcCtD
Bortezomib—Vertigo—Quinidine—malaria	0.000176	0.00102	CcSEcCtD
Bortezomib—Vertigo—Quinine—malaria	0.000176	0.00102	CcSEcCtD
Bortezomib—Syncope—Quinine—malaria	0.000176	0.00102	CcSEcCtD
Bortezomib—Syncope—Quinidine—malaria	0.000176	0.00102	CcSEcCtD
Bortezomib—Leukopenia—Quinidine—malaria	0.000175	0.00101	CcSEcCtD
Bortezomib—Leukopenia—Quinine—malaria	0.000175	0.00101	CcSEcCtD
Bortezomib—Flatulence—Pentoxifylline—malaria	0.000174	0.00101	CcSEcCtD
Bortezomib—Urticaria—Sulfadiazine—malaria	0.000174	0.001	CcSEcCtD
Bortezomib—Palpitations—Quinidine—malaria	0.000173	0.001	CcSEcCtD
Bortezomib—Palpitations—Quinine—malaria	0.000173	0.001	CcSEcCtD
Bortezomib—Body temperature increased—Sulfadiazine—malaria	0.000173	0.001	CcSEcCtD
Bortezomib—Abdominal pain—Sulfadiazine—malaria	0.000173	0.001	CcSEcCtD
Bortezomib—Dysgeusia—Pentoxifylline—malaria	0.000173	0.000999	CcSEcCtD
Bortezomib—Hypertension—Clindamycin—malaria	0.000172	0.000997	CcSEcCtD
Bortezomib—Loss of consciousness—Quinidine—malaria	0.000172	0.000995	CcSEcCtD
Bortezomib—Loss of consciousness—Quinine—malaria	0.000172	0.000995	CcSEcCtD
Bortezomib—Back pain—Pentoxifylline—malaria	0.000171	0.000987	CcSEcCtD
Bortezomib—Convulsion—Quinine—malaria	0.00017	0.000981	CcSEcCtD
Bortezomib—Convulsion—Quinidine—malaria	0.00017	0.000981	CcSEcCtD
Bortezomib—Muscle spasms—Pentoxifylline—malaria	0.00017	0.000981	CcSEcCtD
Bortezomib—Discomfort—Clindamycin—malaria	0.000168	0.000971	CcSEcCtD
Bortezomib—Myalgia—Quinidine—malaria	0.000167	0.000964	CcSEcCtD
Bortezomib—Chest pain—Quinine—malaria	0.000167	0.000964	CcSEcCtD
Bortezomib—Chest pain—Quinidine—malaria	0.000167	0.000964	CcSEcCtD
Bortezomib—Myalgia—Quinine—malaria	0.000167	0.000964	CcSEcCtD
Bortezomib—Vision blurred—Quinidine barbiturate—malaria	0.000167	0.000963	CcSEcCtD
Bortezomib—Vision blurred—Pentoxifylline—malaria	0.000166	0.000961	CcSEcCtD
Bortezomib—Tremor—Quinidine barbiturate—malaria	0.000166	0.000957	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000166	0.000957	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000166	0.000957	CcSEcCtD
Bortezomib—Tremor—Pentoxifylline—malaria	0.000165	0.000956	CcSEcCtD
Bortezomib—Tachycardia—Dapsone—malaria	0.000164	0.00095	CcSEcCtD
Bortezomib—Ill-defined disorder—Pentoxifylline—malaria	0.000164	0.000946	CcSEcCtD
Bortezomib—Anaemia—Pentoxifylline—malaria	0.000163	0.000943	CcSEcCtD
Bortezomib—Anaphylactic shock—Clindamycin—malaria	0.000163	0.000942	CcSEcCtD
Bortezomib—Agitation—Quinidine barbiturate—malaria	0.000163	0.000939	CcSEcCtD
Bortezomib—Agitation—Pentoxifylline—malaria	0.000162	0.000937	CcSEcCtD
Bortezomib—Angioedema—Quinidine barbiturate—malaria	0.000162	0.000934	CcSEcCtD
Bortezomib—Angioedema—Pentoxifylline—malaria	0.000161	0.000932	CcSEcCtD
Bortezomib—Hypersensitivity—Sulfadiazine—malaria	0.000161	0.000932	CcSEcCtD
Bortezomib—Confusional state—Quinine—malaria	0.000161	0.000932	CcSEcCtD
Bortezomib—Confusional state—Quinidine—malaria	0.000161	0.000932	CcSEcCtD
Bortezomib—Oedema—Quinidine—malaria	0.00016	0.000924	CcSEcCtD
Bortezomib—Oedema—Quinine—malaria	0.00016	0.000924	CcSEcCtD
Bortezomib—Thrombocytopenia—Clindamycin—malaria	0.00016	0.000922	CcSEcCtD
Bortezomib—Malaise—Pentoxifylline—malaria	0.000159	0.00092	CcSEcCtD
Bortezomib—Vertigo—Quinidine barbiturate—malaria	0.000159	0.000918	CcSEcCtD
Bortezomib—Syncope—Quinidine barbiturate—malaria	0.000159	0.000916	CcSEcCtD
Bortezomib—Leukopenia—Quinidine barbiturate—malaria	0.000158	0.000915	CcSEcCtD
Bortezomib—Leukopenia—Pentoxifylline—malaria	0.000158	0.000913	CcSEcCtD
Bortezomib—Shock—Quinidine—malaria	0.000157	0.000909	CcSEcCtD
Bortezomib—Shock—Quinine—malaria	0.000157	0.000909	CcSEcCtD
Bortezomib—Nervous system disorder—Quinine—malaria	0.000157	0.000906	CcSEcCtD
Bortezomib—Nervous system disorder—Quinidine—malaria	0.000157	0.000906	CcSEcCtD
Bortezomib—Thrombocytopenia—Quinidine—malaria	0.000157	0.000905	CcSEcCtD
Bortezomib—Thrombocytopenia—Quinine—malaria	0.000157	0.000905	CcSEcCtD
Bortezomib—Palpitations—Quinidine barbiturate—malaria	0.000156	0.000903	CcSEcCtD
Bortezomib—Tachycardia—Quinidine—malaria	0.000156	0.000902	CcSEcCtD
Bortezomib—Tachycardia—Quinine—malaria	0.000156	0.000902	CcSEcCtD
Bortezomib—Palpitations—Pentoxifylline—malaria	0.000156	0.000901	CcSEcCtD
Bortezomib—Loss of consciousness—Quinidine barbiturate—malaria	0.000155	0.000898	CcSEcCtD
Bortezomib—Skin disorder—Quinidine—malaria	0.000155	0.000898	CcSEcCtD
Bortezomib—Skin disorder—Quinine—malaria	0.000155	0.000898	CcSEcCtD
Bortezomib—Pruritus—Sulfadiazine—malaria	0.000155	0.000895	CcSEcCtD
Bortezomib—Hyperhidrosis—Quinine—malaria	0.000155	0.000893	CcSEcCtD
Bortezomib—Hyperhidrosis—Quinidine—malaria	0.000155	0.000893	CcSEcCtD
Bortezomib—Convulsion—Quinidine barbiturate—malaria	0.000153	0.000885	CcSEcCtD
Bortezomib—Convulsion—Pentoxifylline—malaria	0.000153	0.000884	CcSEcCtD
Bortezomib—Anorexia—Quinine—malaria	0.000152	0.000881	CcSEcCtD
Bortezomib—Anorexia—Quinidine—malaria	0.000152	0.000881	CcSEcCtD
Bortezomib—Insomnia—Dapsone—malaria	0.000152	0.000881	CcSEcCtD
Bortezomib—CYP2D6—brain—malaria	0.000152	0.00141	CbGeAlD
Bortezomib—Hypertension—Pentoxifylline—malaria	0.000152	0.000881	CcSEcCtD
Bortezomib—Hypotension—Clindamycin—malaria	0.000152	0.00088	CcSEcCtD
Bortezomib—Myalgia—Quinidine barbiturate—malaria	0.000151	0.00087	CcSEcCtD
Bortezomib—Chest pain—Quinidine barbiturate—malaria	0.000151	0.00087	CcSEcCtD
Bortezomib—Arthralgia—Quinidine barbiturate—malaria	0.000151	0.00087	CcSEcCtD
Bortezomib—Chest pain—Pentoxifylline—malaria	0.00015	0.000868	CcSEcCtD
Bortezomib—Myalgia—Pentoxifylline—malaria	0.00015	0.000868	CcSEcCtD
Bortezomib—Anxiety—Quinidine barbiturate—malaria	0.00015	0.000867	CcSEcCtD
Bortezomib—Diarrhoea—Sulfadiazine—malaria	0.00015	0.000866	CcSEcCtD
Bortezomib—Anxiety—Pentoxifylline—malaria	0.00015	0.000865	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00015	0.000864	CcSEcCtD
Bortezomib—Hypotension—Quinidine—malaria	0.000149	0.000864	CcSEcCtD
Bortezomib—Hypotension—Quinine—malaria	0.000149	0.000864	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000149	0.000862	CcSEcCtD
Bortezomib—Discomfort—Pentoxifylline—malaria	0.000149	0.000858	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Quinidine—malaria	0.000146	0.000842	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Quinine—malaria	0.000146	0.000842	CcSEcCtD
Bortezomib—Confusional state—Quinidine barbiturate—malaria	0.000146	0.000841	CcSEcCtD
Bortezomib—Dyspnoea—Clindamycin—malaria	0.000145	0.00084	CcSEcCtD
Bortezomib—Confusional state—Pentoxifylline—malaria	0.000145	0.000839	CcSEcCtD
Bortezomib—Oedema—Quinidine barbiturate—malaria	0.000144	0.000834	CcSEcCtD
Bortezomib—Anaphylactic shock—Pentoxifylline—malaria	0.000144	0.000833	CcSEcCtD
Bortezomib—Oedema—Pentoxifylline—malaria	0.000144	0.000833	CcSEcCtD
Bortezomib—Dyspepsia—Clindamycin—malaria	0.000144	0.000829	CcSEcCtD
Bortezomib—Infection—Pentoxifylline—malaria	0.000143	0.000827	CcSEcCtD
Bortezomib—Dyspnoea—Quinidine—malaria	0.000143	0.000824	CcSEcCtD
Bortezomib—Dyspnoea—Quinine—malaria	0.000143	0.000824	CcSEcCtD
Bortezomib—Shock—Quinidine barbiturate—malaria	0.000142	0.000821	CcSEcCtD
Bortezomib—Shock—Pentoxifylline—malaria	0.000142	0.000819	CcSEcCtD
Bortezomib—Nervous system disorder—Quinidine barbiturate—malaria	0.000142	0.000818	CcSEcCtD
Bortezomib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000141	0.000817	CcSEcCtD
Bortezomib—Thrombocytopenia—Pentoxifylline—malaria	0.000141	0.000815	CcSEcCtD
Bortezomib—Tachycardia—Quinidine barbiturate—malaria	0.000141	0.000814	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Clindamycin—malaria	0.000141	0.000813	CcSEcCtD
Bortezomib—Tachycardia—Pentoxifylline—malaria	0.000141	0.000813	CcSEcCtD
Bortezomib—Fatigue—Clindamycin—malaria	0.000141	0.000812	CcSEcCtD
Bortezomib—Skin disorder—Quinidine barbiturate—malaria	0.00014	0.00081	CcSEcCtD
Bortezomib—Skin disorder—Pentoxifylline—malaria	0.00014	0.000809	CcSEcCtD
Bortezomib—Hyperhidrosis—Quinidine barbiturate—malaria	0.00014	0.000806	CcSEcCtD
Bortezomib—Pain—Clindamycin—malaria	0.000139	0.000806	CcSEcCtD
Bortezomib—Constipation—Clindamycin—malaria	0.000139	0.000806	CcSEcCtD
Bortezomib—Hyperhidrosis—Pentoxifylline—malaria	0.000139	0.000805	CcSEcCtD
Bortezomib—Vomiting—Sulfadiazine—malaria	0.000139	0.000804	CcSEcCtD
Bortezomib—Decreased appetite—Quinine—malaria	0.000139	0.000803	CcSEcCtD
Bortezomib—Decreased appetite—Quinidine—malaria	0.000139	0.000803	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Quinidine—malaria	0.000138	0.000798	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Quinine—malaria	0.000138	0.000798	CcSEcCtD
Bortezomib—Rash—Sulfadiazine—malaria	0.000138	0.000798	CcSEcCtD
Bortezomib—Dermatitis—Sulfadiazine—malaria	0.000138	0.000797	CcSEcCtD
Bortezomib—Gastrointestinal pain—Dapsone—malaria	0.000138	0.000796	CcSEcCtD
Bortezomib—Anorexia—Quinidine barbiturate—malaria	0.000138	0.000795	CcSEcCtD
Bortezomib—Anorexia—Pentoxifylline—malaria	0.000137	0.000794	CcSEcCtD
Bortezomib—Headache—Sulfadiazine—malaria	0.000137	0.000793	CcSEcCtD
Bortezomib—Hypotension—Quinidine barbiturate—malaria	0.000135	0.000779	CcSEcCtD
Bortezomib—Hypotension—Pentoxifylline—malaria	0.000135	0.000778	CcSEcCtD
Bortezomib—Gastrointestinal pain—Clindamycin—malaria	0.000133	0.00077	CcSEcCtD
Bortezomib—Abdominal pain—Dapsone—malaria	0.000133	0.00077	CcSEcCtD
Bortezomib—Body temperature increased—Dapsone—malaria	0.000133	0.00077	CcSEcCtD
Bortezomib—Feeling abnormal—Quinine—malaria	0.000132	0.000762	CcSEcCtD
Bortezomib—Feeling abnormal—Quinidine—malaria	0.000132	0.000762	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000132	0.00076	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000131	0.000759	CcSEcCtD
Bortezomib—Gastrointestinal pain—Quinidine—malaria	0.000131	0.000756	CcSEcCtD
Bortezomib—Gastrointestinal pain—Quinine—malaria	0.000131	0.000756	CcSEcCtD
Bortezomib—Insomnia—Pentoxifylline—malaria	0.00013	0.000753	CcSEcCtD
Bortezomib—Nausea—Sulfadiazine—malaria	0.00013	0.000751	CcSEcCtD
Bortezomib—Urticaria—Clindamycin—malaria	0.00013	0.000748	CcSEcCtD
Bortezomib—Body temperature increased—Clindamycin—malaria	0.000129	0.000745	CcSEcCtD
Bortezomib—Abdominal pain—Clindamycin—malaria	0.000129	0.000745	CcSEcCtD
Bortezomib—Dyspnoea—Quinidine barbiturate—malaria	0.000129	0.000744	CcSEcCtD
Bortezomib—Dyspnoea—Pentoxifylline—malaria	0.000128	0.000742	CcSEcCtD
Bortezomib—Urticaria—Quinine—malaria	0.000127	0.000734	CcSEcCtD
Bortezomib—Urticaria—Quinidine—malaria	0.000127	0.000734	CcSEcCtD
Bortezomib—Dyspepsia—Pentoxifylline—malaria	0.000127	0.000733	CcSEcCtD
Bortezomib—Abdominal pain—Quinine—malaria	0.000126	0.000731	CcSEcCtD
Bortezomib—Body temperature increased—Quinidine—malaria	0.000126	0.000731	CcSEcCtD
Bortezomib—Body temperature increased—Quinine—malaria	0.000126	0.000731	CcSEcCtD
Bortezomib—Abdominal pain—Quinidine—malaria	0.000126	0.000731	CcSEcCtD
Bortezomib—Decreased appetite—Quinidine barbiturate—malaria	0.000125	0.000725	CcSEcCtD
Bortezomib—Decreased appetite—Pentoxifylline—malaria	0.000125	0.000724	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000125	0.00072	CcSEcCtD
Bortezomib—Pain—Quinidine barbiturate—malaria	0.000123	0.000713	CcSEcCtD
Bortezomib—Constipation—Quinidine barbiturate—malaria	0.000123	0.000713	CcSEcCtD
Bortezomib—Constipation—Pentoxifylline—malaria	0.000123	0.000712	CcSEcCtD
Bortezomib—Hypersensitivity—Clindamycin—malaria	0.00012	0.000694	CcSEcCtD
Bortezomib—Feeling abnormal—Quinidine barbiturate—malaria	0.000119	0.000687	CcSEcCtD
Bortezomib—Feeling abnormal—Pentoxifylline—malaria	0.000119	0.000686	CcSEcCtD
Bortezomib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000118	0.000682	CcSEcCtD
Bortezomib—Hypersensitivity—Quinidine—malaria	0.000118	0.000681	CcSEcCtD
Bortezomib—Hypersensitivity—Quinine—malaria	0.000118	0.000681	CcSEcCtD
Bortezomib—Gastrointestinal pain—Pentoxifylline—malaria	0.000118	0.000681	CcSEcCtD
Bortezomib—Asthenia—Clindamycin—malaria	0.000117	0.000676	CcSEcCtD
Bortezomib—Pruritus—Clindamycin—malaria	0.000115	0.000666	CcSEcCtD
Bortezomib—Asthenia—Quinidine—malaria	0.000115	0.000663	CcSEcCtD
Bortezomib—Asthenia—Quinine—malaria	0.000115	0.000663	CcSEcCtD
Bortezomib—Urticaria—Quinidine barbiturate—malaria	0.000115	0.000663	CcSEcCtD
Bortezomib—Urticaria—Pentoxifylline—malaria	0.000114	0.000661	CcSEcCtD
Bortezomib—Abdominal pain—Quinidine barbiturate—malaria	0.000114	0.000659	CcSEcCtD
Bortezomib—Body temperature increased—Quinidine barbiturate—malaria	0.000114	0.000659	CcSEcCtD
Bortezomib—Abdominal pain—Pentoxifylline—malaria	0.000114	0.000658	CcSEcCtD
Bortezomib—Body temperature increased—Pentoxifylline—malaria	0.000114	0.000658	CcSEcCtD
Bortezomib—Pruritus—Quinidine—malaria	0.000113	0.000654	CcSEcCtD
Bortezomib—Pruritus—Quinine—malaria	0.000113	0.000654	CcSEcCtD
Bortezomib—Diarrhoea—Clindamycin—malaria	0.000112	0.000645	CcSEcCtD
Bortezomib—Diarrhoea—Quinidine—malaria	0.000109	0.000632	CcSEcCtD
Bortezomib—Diarrhoea—Quinine—malaria	0.000109	0.000632	CcSEcCtD
Bortezomib—Dizziness—Clindamycin—malaria	0.000108	0.000623	CcSEcCtD
Bortezomib—Vomiting—Dapsone—malaria	0.000107	0.000619	CcSEcCtD
Bortezomib—Hypersensitivity—Quinidine barbiturate—malaria	0.000106	0.000614	CcSEcCtD
Bortezomib—Hypersensitivity—Pentoxifylline—malaria	0.000106	0.000613	CcSEcCtD
Bortezomib—Dizziness—Quinine—malaria	0.000106	0.000611	CcSEcCtD
Bortezomib—Dizziness—Quinidine—malaria	0.000106	0.000611	CcSEcCtD
Bortezomib—Headache—Dapsone—malaria	0.000106	0.00061	CcSEcCtD
Bortezomib—Vomiting—Clindamycin—malaria	0.000104	0.000599	CcSEcCtD
Bortezomib—Asthenia—Quinidine barbiturate—malaria	0.000104	0.000598	CcSEcCtD
Bortezomib—Asthenia—Pentoxifylline—malaria	0.000103	0.000597	CcSEcCtD
Bortezomib—Rash—Clindamycin—malaria	0.000103	0.000594	CcSEcCtD
Bortezomib—Dermatitis—Clindamycin—malaria	0.000103	0.000593	CcSEcCtD
Bortezomib—Headache—Clindamycin—malaria	0.000102	0.00059	CcSEcCtD
Bortezomib—Pruritus—Quinidine barbiturate—malaria	0.000102	0.00059	CcSEcCtD
Bortezomib—Pruritus—Pentoxifylline—malaria	0.000102	0.000589	CcSEcCtD
Bortezomib—Vomiting—Quinidine—malaria	0.000102	0.000588	CcSEcCtD
Bortezomib—Vomiting—Quinine—malaria	0.000102	0.000588	CcSEcCtD
Bortezomib—Rash—Quinidine—malaria	0.000101	0.000583	CcSEcCtD
Bortezomib—Rash—Quinine—malaria	0.000101	0.000583	CcSEcCtD
Bortezomib—Dermatitis—Quinidine—malaria	0.000101	0.000582	CcSEcCtD
Bortezomib—Dermatitis—Quinine—malaria	0.000101	0.000582	CcSEcCtD
Bortezomib—Headache—Quinine—malaria	0.0001	0.000579	CcSEcCtD
Bortezomib—Headache—Quinidine—malaria	0.0001	0.000579	CcSEcCtD
Bortezomib—Nausea—Dapsone—malaria	0.0001	0.000578	CcSEcCtD
Bortezomib—Diarrhoea—Quinidine barbiturate—malaria	9.88e-05	0.000571	CcSEcCtD
Bortezomib—Diarrhoea—Pentoxifylline—malaria	9.86e-05	0.00057	CcSEcCtD
Bortezomib—Nausea—Clindamycin—malaria	9.68e-05	0.00056	CcSEcCtD
Bortezomib—Dizziness—Quinidine barbiturate—malaria	9.55e-05	0.000552	CcSEcCtD
Bortezomib—Dizziness—Pentoxifylline—malaria	9.53e-05	0.000551	CcSEcCtD
Bortezomib—Nausea—Quinidine—malaria	9.5e-05	0.000549	CcSEcCtD
Bortezomib—Nausea—Quinine—malaria	9.5e-05	0.000549	CcSEcCtD
Bortezomib—Vomiting—Quinidine barbiturate—malaria	9.18e-05	0.00053	CcSEcCtD
Bortezomib—Vomiting—Pentoxifylline—malaria	9.16e-05	0.000529	CcSEcCtD
Bortezomib—Rash—Quinidine barbiturate—malaria	9.1e-05	0.000526	CcSEcCtD
Bortezomib—Dermatitis—Quinidine barbiturate—malaria	9.09e-05	0.000525	CcSEcCtD
Bortezomib—Rash—Pentoxifylline—malaria	9.08e-05	0.000525	CcSEcCtD
Bortezomib—Dermatitis—Pentoxifylline—malaria	9.08e-05	0.000524	CcSEcCtD
Bortezomib—Headache—Quinidine barbiturate—malaria	9.04e-05	0.000523	CcSEcCtD
Bortezomib—Headache—Pentoxifylline—malaria	9.03e-05	0.000522	CcSEcCtD
Bortezomib—Nausea—Quinidine barbiturate—malaria	8.57e-05	0.000495	CcSEcCtD
Bortezomib—Nausea—Pentoxifylline—malaria	8.56e-05	0.000495	CcSEcCtD
Bortezomib—PSMB8—Adaptive Immune System—ICAM1—malaria	4.21e-05	0.000772	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HLA-B—malaria	4.21e-05	0.000772	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—HPGDS—malaria	4.2e-05	0.00077	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—HPGDS—malaria	4.2e-05	0.00077	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—HPGDS—malaria	4.2e-05	0.00077	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-B—malaria	4.19e-05	0.000768	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-B—malaria	4.17e-05	0.000764	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—IL6—malaria	4.16e-05	0.000763	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CD4—malaria	4.14e-05	0.00076	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—HPGDS—malaria	4.14e-05	0.000759	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD36—malaria	4.13e-05	0.000757	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD4—malaria	4.12e-05	0.000756	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD36—malaria	4.11e-05	0.000753	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CD4—malaria	4.1e-05	0.000752	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD36—malaria	4.09e-05	0.00075	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	4.04e-05	0.000741	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—DECR1—malaria	4.01e-05	0.000734	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—DHFR—malaria	3.89e-05	0.000714	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—DHFR—malaria	3.89e-05	0.000714	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—DHFR—malaria	3.89e-05	0.000714	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	3.89e-05	0.000714	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	3.89e-05	0.000714	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—SCARB1—malaria	3.85e-05	0.000707	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—SCARB1—malaria	3.85e-05	0.000707	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—SCARB1—malaria	3.85e-05	0.000707	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—DHFR—malaria	3.84e-05	0.000704	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—SCARB1—malaria	3.8e-05	0.000697	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CRP—malaria	3.72e-05	0.000682	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CRP—malaria	3.7e-05	0.000679	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CRP—malaria	3.69e-05	0.000676	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—HBB—malaria	3.62e-05	0.000664	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—TLR4—malaria	3.57e-05	0.000654	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—TLR4—malaria	3.55e-05	0.000651	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—TLR4—malaria	3.53e-05	0.000648	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—DHODH—malaria	3.53e-05	0.000647	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.47e-05	0.000636	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—ICAM1—malaria	3.42e-05	0.000627	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—ICAM1—malaria	3.4e-05	0.000624	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—ICAM1—malaria	3.39e-05	0.000621	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL18—malaria	3.37e-05	0.000617	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL18—malaria	3.37e-05	0.000617	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL18—malaria	3.37e-05	0.000617	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD40LG—malaria	3.35e-05	0.000615	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD40LG—malaria	3.35e-05	0.000615	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD40LG—malaria	3.35e-05	0.000615	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL18—malaria	3.32e-05	0.000609	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD8A—malaria	3.32e-05	0.000608	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD8A—malaria	3.32e-05	0.000608	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD8A—malaria	3.32e-05	0.000608	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD40LG—malaria	3.31e-05	0.000606	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD8A—malaria	3.27e-05	0.000599	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—DHODH—malaria	3.24e-05	0.000593	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PKLR—malaria	3.23e-05	0.000592	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CD36—malaria	3.19e-05	0.000585	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-B—malaria	3.19e-05	0.000585	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-B—malaria	3.19e-05	0.000585	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-B—malaria	3.19e-05	0.000585	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.19e-05	0.000584	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.18e-05	0.000584	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CD36—malaria	3.18e-05	0.000582	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CD36—malaria	3.16e-05	0.00058	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-B—malaria	3.15e-05	0.000577	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD4—malaria	3.14e-05	0.000576	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD4—malaria	3.14e-05	0.000576	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD4—malaria	3.14e-05	0.000576	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NOS2—malaria	3.13e-05	0.000574	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD36—malaria	3.13e-05	0.000573	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD36—malaria	3.13e-05	0.000573	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD36—malaria	3.13e-05	0.000573	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NOS2—malaria	3.12e-05	0.000572	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—IL6—malaria	3.11e-05	0.00057	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NOS2—malaria	3.1e-05	0.000569	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CD4—malaria	3.1e-05	0.000568	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD36—malaria	3.08e-05	0.000565	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SLC4A1—malaria	3e-05	0.00055	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.92e-05	0.000536	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DHODH—malaria	2.89e-05	0.00053	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—G6PD—malaria	2.88e-05	0.000528	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.84e-05	0.000521	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	2.84e-05	0.000521	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—DECR1—malaria	2.82e-05	0.000517	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CRP—malaria	2.82e-05	0.000517	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CRP—malaria	2.82e-05	0.000517	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CRP—malaria	2.82e-05	0.000517	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CRP—malaria	2.78e-05	0.00051	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SLC4A1—malaria	2.75e-05	0.000504	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—TLR4—malaria	2.7e-05	0.000496	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—TLR4—malaria	2.7e-05	0.000496	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—TLR4—malaria	2.7e-05	0.000496	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—TLR4—malaria	2.67e-05	0.000489	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DHODH—malaria	2.66e-05	0.000487	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DHODH—malaria	2.63e-05	0.000483	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.61e-05	0.000478	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IFNG—malaria	2.6e-05	0.000477	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ICAM1—malaria	2.59e-05	0.000475	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ICAM1—malaria	2.59e-05	0.000475	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—ICAM1—malaria	2.59e-05	0.000475	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.59e-05	0.000475	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IFNG—malaria	2.59e-05	0.000475	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—DECR1—malaria	2.59e-05	0.000474	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IFNG—malaria	2.58e-05	0.000473	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ICAM1—malaria	2.56e-05	0.000468	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—HBB—malaria	2.55e-05	0.000468	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD4—malaria	2.51e-05	0.000461	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD4—malaria	2.5e-05	0.000459	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD4—malaria	2.49e-05	0.000456	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SLC4A1—malaria	2.46e-05	0.00045	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CD36—malaria	2.42e-05	0.000443	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CD36—malaria	2.42e-05	0.000443	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CD36—malaria	2.42e-05	0.000443	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CD36—malaria	2.38e-05	0.000437	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.38e-05	0.000436	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NOS2—malaria	2.37e-05	0.000435	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NOS2—malaria	2.37e-05	0.000435	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NOS2—malaria	2.37e-05	0.000435	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NOS2—malaria	2.34e-05	0.000429	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—HBB—malaria	2.34e-05	0.000429	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL1B—malaria	2.32e-05	0.000426	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CD4—malaria	2.32e-05	0.000425	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL2—malaria	2.31e-05	0.000424	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL1B—malaria	2.31e-05	0.000424	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CD4—malaria	2.31e-05	0.000423	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DECR1—malaria	2.31e-05	0.000423	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—KDR—malaria	2.31e-05	0.000423	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL2—malaria	2.3e-05	0.000422	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL1B—malaria	2.3e-05	0.000422	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CD4—malaria	2.3e-05	0.000421	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—KDR—malaria	2.3e-05	0.000421	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL2—malaria	2.29e-05	0.00042	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—KDR—malaria	2.28e-05	0.000419	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PKLR—malaria	2.27e-05	0.000417	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SLC4A1—malaria	2.26e-05	0.000414	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DHODH—malaria	2.25e-05	0.000413	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SLC4A1—malaria	2.24e-05	0.000411	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.21e-05	0.000406	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—HPGDS—malaria	2.19e-05	0.000402	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DECR1—malaria	2.12e-05	0.000389	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DECR1—malaria	2.11e-05	0.000386	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HBB—malaria	2.09e-05	0.000383	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PKLR—malaria	2.09e-05	0.000382	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—DHFR—malaria	2.04e-05	0.000373	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.03e-05	0.000373	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—G6PD—malaria	2.03e-05	0.000372	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—SCARB1—malaria	2.02e-05	0.000369	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	2e-05	0.000367	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IFNG—malaria	1.97e-05	0.000362	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IFNG—malaria	1.97e-05	0.000362	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IFNG—malaria	1.97e-05	0.000362	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IFNG—malaria	1.94e-05	0.000356	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HBB—malaria	1.92e-05	0.000352	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC4A1—malaria	1.91e-05	0.000351	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD4—malaria	1.9e-05	0.000349	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD4—malaria	1.9e-05	0.000349	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD4—malaria	1.9e-05	0.000349	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HBB—malaria	1.9e-05	0.000349	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD4—malaria	1.88e-05	0.000344	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PKLR—malaria	1.86e-05	0.000341	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—G6PD—malaria	1.86e-05	0.000341	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.83e-05	0.000336	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DECR1—malaria	1.8e-05	0.00033	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1B—malaria	1.76e-05	0.000323	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1B—malaria	1.76e-05	0.000323	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL1B—malaria	1.76e-05	0.000323	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CD4—malaria	1.76e-05	0.000322	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CD4—malaria	1.76e-05	0.000322	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CD4—malaria	1.76e-05	0.000322	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL2—malaria	1.75e-05	0.000321	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL2—malaria	1.75e-05	0.000321	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL2—malaria	1.75e-05	0.000321	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—KDR—malaria	1.75e-05	0.00032	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—KDR—malaria	1.75e-05	0.00032	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—KDR—malaria	1.75e-05	0.00032	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DHODH—malaria	1.74e-05	0.000318	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL1B—malaria	1.73e-05	0.000318	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CD4—malaria	1.73e-05	0.000318	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL2—malaria	1.73e-05	0.000317	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—KDR—malaria	1.72e-05	0.000316	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PKLR—malaria	1.71e-05	0.000314	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PKLR—malaria	1.7e-05	0.000311	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—G6PD—malaria	1.66e-05	0.000304	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	1.64e-05	0.0003	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HBB—malaria	1.63e-05	0.000298	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—HPGDS—malaria	1.55e-05	0.000283	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—G6PD—malaria	1.53e-05	0.00028	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—G6PD—malaria	1.51e-05	0.000277	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL2—malaria	1.5e-05	0.000274	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.49e-05	0.000274	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL2—malaria	1.49e-05	0.000273	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL2—malaria	1.48e-05	0.000272	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC4A1—malaria	1.48e-05	0.000271	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PKLR—malaria	1.45e-05	0.000266	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—DHFR—malaria	1.43e-05	0.000263	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SCARB1—malaria	1.42e-05	0.00026	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—HPGDS—malaria	1.42e-05	0.00026	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DECR1—malaria	1.39e-05	0.000255	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL6—malaria	1.36e-05	0.000249	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL6—malaria	1.35e-05	0.000248	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL6—malaria	1.35e-05	0.000247	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—DHFR—malaria	1.32e-05	0.000241	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SCARB1—malaria	1.3e-05	0.000239	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—G6PD—malaria	1.29e-05	0.000237	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.28e-05	0.000234	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HPGDS—malaria	1.27e-05	0.000232	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CD36—malaria	1.26e-05	0.000232	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HBB—malaria	1.26e-05	0.00023	CbGpPWpGaD
Bortezomib—PSMA1—Disease—IL6—malaria	1.26e-05	0.00023	CbGpPWpGaD
Bortezomib—PSMD1—Disease—IL6—malaria	1.25e-05	0.000229	CbGpPWpGaD
Bortezomib—PSMD2—Disease—IL6—malaria	1.24e-05	0.000228	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DHFR—malaria	1.17e-05	0.000215	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HPGDS—malaria	1.16e-05	0.000213	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SCARB1—malaria	1.16e-05	0.000213	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HPGDS—malaria	1.15e-05	0.000212	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL2—malaria	1.13e-05	0.000208	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL2—malaria	1.13e-05	0.000208	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL2—malaria	1.13e-05	0.000208	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PKLR—malaria	1.12e-05	0.000205	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL2—malaria	1.12e-05	0.000205	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DHFR—malaria	1.08e-05	0.000198	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DHFR—malaria	1.07e-05	0.000196	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SCARB1—malaria	1.07e-05	0.000196	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SCARB1—malaria	1.06e-05	0.000194	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL6—malaria	1.03e-05	0.000189	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL6—malaria	1.03e-05	0.000189	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL6—malaria	1.03e-05	0.000189	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL6—malaria	1.02e-05	0.000186	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—G6PD—malaria	9.98e-06	0.000183	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HPGDS—malaria	9.86e-06	0.000181	CbGpPWpGaD
Bortezomib—PSMB5—Disease—IL6—malaria	9.51e-06	0.000174	CbGpPWpGaD
Bortezomib—PSMB1—Disease—IL6—malaria	9.51e-06	0.000174	CbGpPWpGaD
Bortezomib—PSMB2—Disease—IL6—malaria	9.51e-06	0.000174	CbGpPWpGaD
Bortezomib—PSMB8—Disease—IL6—malaria	9.38e-06	0.000172	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DHFR—malaria	9.15e-06	0.000168	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SCARB1—malaria	9.05e-06	0.000166	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CD36—malaria	8.91e-06	0.000163	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL6—malaria	8.79e-06	0.000161	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL6—malaria	8.75e-06	0.00016	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL6—malaria	8.71e-06	0.00016	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CD36—malaria	8.17e-06	0.00015	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HPGDS—malaria	7.61e-06	0.000139	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CD36—malaria	7.29e-06	0.000134	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DHFR—malaria	7.06e-06	0.000129	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SCARB1—malaria	6.99e-06	0.000128	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CD36—malaria	6.71e-06	0.000123	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—malaria	6.66e-06	0.000122	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—malaria	6.66e-06	0.000122	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—malaria	6.66e-06	0.000122	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CD36—malaria	6.65e-06	0.000122	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—malaria	6.57e-06	0.00012	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CD36—malaria	5.68e-06	0.000104	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CD36—malaria	4.38e-06	8.04e-05	CbGpPWpGaD
